gadolinium dtpa has been researched along with sb 239063 in 1 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (sb 239063) | Trials (sb 239063) | Recent Studies (post-2010) (sb 239063) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 84 | 0 | 35 |
| Protein | Taxonomy | gadolinium dtpa (IC50) | sb 239063 (IC50) |
|---|---|---|---|
| Mitogen-activated protein kinase 13 | Homo sapiens (human) | 0.044 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 0.083 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 0.018 | |
| Protein kinase C alpha type | Homo sapiens (human) | 0.083 | |
| Mitogen-activated protein kinase 9 | Homo sapiens (human) | 0.005 | |
| Mitogen-activated protein kinase 12 | Homo sapiens (human) | 0.044 | |
| Mitogen-activated protein kinase 11 | Homo sapiens (human) | 0.044 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.0415 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, DF; Boyce, RW; Jucker, BM; Lenhard, SC; Mirabile, RC; Nerurkar, SS; Schaeffer, TR; Willette, RN | 1 |
1 other study(ies) available for gadolinium dtpa and sb 239063
| Article | Year |
|---|---|
p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 2. Improved renal function as assessed by dynamic contrast-enhanced magnetic resonance imaging.
Topics: Albuminuria; Animals; Contrast Media; Creatinine; Dietary Fats; Endothelium, Vascular; Enzyme Inhibitors; Gadolinium DTPA; Glomerular Filtration Rate; Hypertension; Imidazoles; In Vitro Techniques; Kidney; Kidney Function Tests; Magnetic Resonance Imaging; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pyrimidines; Rats; Rats, Inbred SHR; Sodium, Dietary; Stroke | 2003 |